Latest News
Sigma Healthcare Shares Dip Ahead of Key Half-Year Results
Sigma Healthcare shares declined nearly 1% in Monday trading as investors await the company's half-year financial report due February 26, focusing on margin performance and cost management.
Westpac Shares Climb to $40 Amid ASX Rally Ahead of Key Quarterly Report
Westpac shares rose 1.47% to A$40.01 as the ASX 200 gained 1.85%. Investors await the bank's quarterly update on February 13, focusing on net interest margins and credit quality.
CSL Shares Edge Lower Ahead of Key Half-Year Results and Dividend Announcement
CSL shares closed slightly lower as trading volume remained subdued, with investor focus shifting to the company's upcoming half-year financial results and interim dividend announcement scheduled for Wednesday.
Commonwealth Bank Shares Steady Ahead of Key Earnings and Dividend Announcement
Commonwealth Bank of Australia shares held near A$160 as investors await the bank's half-year results and interim dividend decision due Wednesday.
ANZ Shares Gain Ahead of Key Quarterly Update and Mortgage Rate Hike
ANZ shares rose 1.7% to A$37.63 as investors await Thursday's first-quarter trading update. The bank will increase variable home loan rates by 0.25 percentage points from February 13.
WiseTech Global Rebounds 4.3% as Tech Sector Stabilizes, Eyes on Upcoming Earnings
WiseTech Global shares surged 4.3% to A$49.66, recovering from recent software sector declines. Investors now await the company's half-year results scheduled for February 25.
Nebius AI Stock Undervalued Amid Projected Revenue Surge to $9B
Nebius Group's AI computing stock appears discounted with forward P/S under 7, as revenue is projected to leap from $551M to up to $9B in 2026. Meanwhile, Asian dividend stocks and blockchain leaders attract investor attention.
AT&T Shares Dip Amid Broad Market Gains, Focus Shifts to Key Economic Data
AT&T stock declined 0.7% to $27.13 on Friday, underperforming a broader market rally that pushed the Dow Jones Industrial Average above 50,000. Investors are now awaiting delayed U.S. employment and inflation reports.
Gilead Hits 52-Week Peak on FDA Label Expansion for Yescarta, Earnings in Focus
Gilead Sciences reached a 52-week high after the FDA approved a label update for its Yescarta therapy, expanding use to a rare brain lymphoma. The stock's rally comes ahead of the company's quarterly earnings report.
Abbott Shares Gain on Insider Purchase and Positive Cardiac Device Data
Abbott Laboratories stock rose 1.6% Friday following a director's $1.09 million share purchase and new clinical data for its heart rhythm devices presented at a medical symposium.
Disney Shares Face Regulatory Scrutiny as FCC Probes ABC Talk Show
Walt Disney Co's stock will be monitored Monday after U.S. regulators launched an investigation into ABC's 'The View' regarding election airtime rules. Shares closed Friday at $108.70, up 3.6%.
Texas Instruments Slashes Capex, Eyes Silicon Labs Deal Amid Insider Sales
Texas Instruments shares fell 1.13% as the company plans to cut 2026 capital spending to $2-3 billion and fund its Silicon Labs acquisition with cash and debt. Key executives sold shares after exercising options.